Skip to content

Efficacy of Bundled Intervention in reducing surgical site infections among patients undergoing clean orthopedic surgery with hardware implants.

Effectiveness of bundled intervention in surgical site infections among patients undergoing clean orthopedic surgery with hardware implants: A randomized controlled trial.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/03/006767
Enrollment
1720
Registered
2016-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M968- Other intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified Health Condition 2: null- Patients posted for clean orthopedic surgery with hardware implants.

Interventions

Intervention1: Bundled Intervention: a. Screening: Using a sterile cotton swab, the anterior nares of the eligible patients will be swabbed during scheduled pre-operative clinic visits (usually 10-14

Sponsors

AIIMS hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients posted for clean orthopedic surgery with hardware implants

Exclusion criteria

Exclusion criteria: i) Patients under 18 years of age ii) Patients who refuse to give informed consent iii) Patients with revision and/or dirty surgeries or with pre-existing infections at the surgical site.

Design outcomes

Primary

MeasureTime frame
Establishment of Bundled intervention as a standard pre-operative preventive measure to reduce surgical site infections among patients undergoing clean orthopedic surgery with hardware implants.Timepoint: To end of the study (09.10.22)

Secondary

MeasureTime frame
Costing of bundled intervention versus current standard practice/patient.Timepoint: To end of the study (09.10.22);To compare the incidence of surgical site infections between intervention group asnd control group.Timepoint: To the end of the study (09.10.22)

Countries

India

Contacts

Public ContactDr Benu Dhawan

All India Institute of Medical Sciences, New Delhi

dhawanb@gmail.com011-2654-6444

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026